INTRAVENOUS ADMINISTRATION OF INDOKLON® 10% SOLUTION
KURT NUSSBAUM M. D., and
ALBERT A. KURLAND M. D.1
1 Research Dept., Spring Grove State Hospital, Baltimore, Md.
A group of 14 psychotic patients displaying depressive and schizo-affective symptomatology who had not responded to psychotropic drug therapies were treated with a 10% solution of Indoklon administered intravenously. The patients received a total of 85 treatments. Observations indicated that administration of the 10% solution brought about symptomatic improvement similar to that which would have been obtained with ECT. Administration of the 10% solution appears to be essentially free of the complaints associated with the 5% solution previously used.
